"The solid financial footing also has Genmab on the acquisition hunt to further bolster the portfolio, specifically in search of molecules in later stages of development."
Could be a potential suitor. Link to article below -
Genmab's growth plan entails partnering less, owning more: CEO (fiercebiotech.com)
"The solid financial footing also has Genmab on the acquisition...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $5.35K | 700.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 8854419 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 3165475 | 3 |
View Market Depth
| Last trade - 11.38am 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 496000 | ||
| Last updated 15.57pm 03/06/2024 ? | |||||
| PAB (ASX) Chart |